Patents by Inventor Hsiao-Chu Huang

Hsiao-Chu Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150079202
    Abstract: The present invention provides a method or composition for inhibiting the infection of a microorganism in a subject, using a Plectranthus amboinicus (Lour.) Spreng extract. Also provided is a method or composition for treating or preventing acne vulgaris caused by microorganisms, particularly Propionibacterium acnes, Staphylococcus aureus, and Pseudomonas aeruginosa.
    Type: Application
    Filed: September 3, 2014
    Publication date: March 19, 2015
    Inventors: HUI-CHUN CHEN, JEN-WEI CHEN, HSIAO-CHU HUANG, WEI-LUEN CHANG
  • Patent number: 8257759
    Abstract: An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the Morus australis Poir extract as an active component. The effective Morus australis Poir extract is prepared by extracting the root-bark of the Morus australis Poir with water, ethanol, acetone, ethyl acetate, or a combination thereof. The crude extract can be further fractioned by ultrafiltration or reverse phase column.
    Type: Grant
    Filed: December 25, 2008
    Date of Patent: September 4, 2012
    Assignee: Medical and Pharmaceutical Industry Technology and Development Center
    Inventors: Yuan-Ling Ku, Chien-Jen Shih, Hsiao-Chu Huang, Chun-Hung Kuo, Yi-Chen Lin, Yueh-Chu Chen, Feng-Nien Ko
  • Publication number: 20100166890
    Abstract: An antitussive composition is provided. A pharmaceutical composition for relieving, preventing and/or treating a cough includes a sufficient amount of the Morus australis Poir extract as an active component. The effective Morus australis Poir extract is prepared by extracting the root-bark of the Morus australis Poir with water, ethanol, acetone, ethyl acetate, or a combination thereof. The crude extract can be further fractioned by ultrafiltration or reverse phase column.
    Type: Application
    Filed: December 25, 2008
    Publication date: July 1, 2010
    Applicant: Pharmaceutical Industry Technology and Development Center
    Inventors: Yuan-Ling Ku, Chien-Jen Shih, Hsiao-Chu Huang, Chun-Hung Kuo, Yi-Chen Lin, Yueh-Chu Chen